Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX: RMDA)
Egypt
· Delayed Price · Currency is EGP 3.710
+0.060 (1.64%)
At close: Jan 29, 2025
EGX: RMDA Revenue
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. had revenue of 763.23M EGP in the quarter ending September 30, 2024, with 39.86% growth. This brings the company's revenue in the last twelve months to 2.32B, up 30.32% year-over-year. In the year 2023, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. had annual revenue of 1.92B with 29.54% growth.
Revenue (ttm)
2.32B
Revenue Growth
+30.32%
P/S Ratio
2.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.58B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Commercial International Bank (Egypt) S.A.E | 100.42B |
| El Sewedy Electric Company | 208.20B |
| Talaat Moustafa Group Holding | 37.97B |
| Eastern Company S.A.E | 25.47B |
| Misr Fertilizer Production Company | 5.80B |
| Ezz Steel Company (S.A.E) | 181.34B |
| Alexandria Container&Cargo Handling Company | 7.49B |
| Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 17.82B |